Uniphar (UPR) Stock Overview
Operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
UPR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Uniphar plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.02 |
| 52 Week High | €3.12 |
| 52 Week Low | €1.63 |
| Beta | 0.95 |
| 1 Month Change | 18.90% |
| 3 Month Change | 37.27% |
| 1 Year Change | 37.27% |
| 3 Year Change | -0.17% |
| 5 Year Change | 98.28% |
| Change since IPO | 213.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| UPR | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0.3% | 4.4% | 0.6% |
| 1Y | 37.3% | -6.6% | 3.9% |
Return vs Industry: UPR exceeded the UK Healthcare industry which returned -9.5% over the past year.
Return vs Market: UPR exceeded the UK Market which returned 3.8% over the past year.
Price Volatility
| UPR volatility | |
|---|---|
| UPR Average Weekly Movement | 3.8% |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in GB Market | 11.2% |
| 10% least volatile stocks in GB Market | 3.3% |
Stable Share Price: UPR has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: UPR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 3,500 | Ger Rabbette | www.uniphar.ie |
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels.
Uniphar plc Fundamentals Summary
| UPR fundamental statistics | |
|---|---|
| Market cap | UK£780.73m |
| Earnings (TTM) | UK£54.09m |
| Revenue (TTM) | UK£2.33b |
Is UPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UPR income statement (TTM) | |
|---|---|
| Revenue | €2.77b |
| Cost of Revenue | €2.34b |
| Gross Profit | €427.60m |
| Other Expenses | €363.40m |
| Earnings | €64.20m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.25 |
| Gross Margin | 15.43% |
| Net Profit Margin | 2.32% |
| Debt/Equity Ratio | 62.4% |
How did UPR perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/04 14:19 |
| End of Day Share Price | 2025/06/04 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Uniphar plc is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eoghan Reid | Berenberg |
| Calum Battersby | Berenberg |
| Samuel England | Berenberg |